Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Daniel Guilfoyle"'
Autor:
Michael Barnett, Dongang Wang, Heidi Beadnall, Antje Bischof, David Brunacci, Helmut Butzkueven, J. William L. Brown, Mariano Cabezas, Tilak Das, Tej Dugal, Daniel Guilfoyle, Alexander Klistorner, Stephen Krieger, Kain Kyle, Linda Ly, Lynette Masters, Andy Shieh, Zihao Tang, Anneke van der Walt, Kayla Ward, Heinz Wiendl, Geng Zhan, Robert Zivadinov, Yael Barnett, Chenyu Wang
Publikováno v:
npj Digital Medicine, Vol 6, Iss 1, Pp 1-9 (2023)
Abstract Modern management of MS targets No Evidence of Disease Activity (NEDA): no clinical relapses, no magnetic resonance imaging (MRI) disease activity and no disability worsening. While MRI is the principal tool available to neurologists for mon
Externí odkaz:
https://doaj.org/article/005f3e28006d4f32a648ee660434318a
Autor:
Daniel Guilfoyle, Kenneth Cho, Christopher L. Brown, Marille Umakanthan, Muralikrishna Gangadharan Komala, Derek Boersma, Kamal Sud, Gustavo Duque, John Wing Li
Publikováno v:
Nutrients, Vol 13, Iss 3284, p 3284 (2021)
Nutrients
Volume 13
Issue 9
Nutrients
Volume 13
Issue 9
Background: Sarcopenia is associated with significant morbidity and mortality in patients with chronic kidney disease. The prevalence of sarcopenia in the dialysis population varies from 4% to 63%. However, the prevalence and risk factors of sarcopen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3417ee8c486e8696f8283c1bda7c7e9d
https://www.mdpi.com/2072-6643/13/9/3284
https://www.mdpi.com/2072-6643/13/9/3284